15 July 2019 in The Journal of Immunology
IFN belong to a group of cytokines specialized in the immunity to viruses. Upon viral infection, type I IFN is produced and alters the transcriptome of responding cells through induction of a set of IFN stimulated genes (ISGs) with regulatory or antiviral function, resulting in a cellular antiviral state. Fish genomes have both type I IFN and type II IFN (IFN-γ), but no type III (λ) IFN has been identified. Their receptors are not simple counterparts of the mammalian type I/II IFN receptors, because alternative chains are used in type I IFN receptors. The mechanisms of the downstream signaling remain partly undefined. In mammals, members of the signal transducer and activator of family of transcription factors are responsible for the transmission of the signal from cytokine receptors, and STAT2 is required for type I but not type II IFN signaling. In fish, its role in IFN signaling in fish remains unclear. We isolated a Chinook salmon (Oncorhynchus tshawytscha) cell line, GS2, with a stat2 gene knocked out by CRISPR/Cas9 genome editing. In this cell line, the induction of ISGs by stimulation with a recombinant type I IFN is completely obliterated as evidenced by comparative RNA-seq analysis of the transcriptome of GS2 and its parental counterpart, EC. Despite a complete absence of ISGs induction, the GS2 cell line has a remarkable ability to resist to viral infections. Therefore, other STAT2-independent pathways may be induced by the viral infection, illustrating the robustness and redundancy of the innate antiviral defenses in fish. Key points A stat2−/−Oncorhynchus tshawytscha cell line was isolated. STAT2 is required for type I but not type II signaling in salmonid cells.
18 January 2021 in Journal of Fish Diseases
5 August 2022 in Fish & Shellfish Immunology
6 September 2024 in Journal of Fish Diseases
The common carp is one of the most economically valuable freshwater fish worldwide and its aquaculture can be severely affected by the koi sleepy disease (KSD)/carp edema virus disease (CEVD). This study explores a natural outbreak of CEVD in a pond containing both clinically healthy and diseased fish of various origins exposed to the virus. We investigated mRNA expression of genes associated with known antiviral immune mechanisms, such as type I interferon signalling and cell‐mediated cytotoxicity, and performed a comprehensive protein expression analysis to highlight differences between the two groups in various organs. Significant differences in expression profiles of common carp with and without clinical signs were found to be strongly dependent on the organ from which the sample originated. Components of the complement cascade, including various C3 proteins, exhibited upregulation only in less affected organs, specifically the head kidney and spleen. Other complement proteins such as B/C2 and C9 showed upregulation in the kidney, spleen, and gills but not in the skin. Conversely, lysozymes C and G, were observed to be upregulated in the most affected organs of the skin and gills. This study submits the first description of the immune system related proteome using a mass spectrometry on the samples isolated from fish infected with CEV. It also offers a unique comparison of immune reaction of CEV infected and healthy fish under an infectious pressure.
10 July 2026 in SSRN Electronic Journal
The skin serves as a vital barrier requiring effective healing following injury. This study explores protein-based biomaterials, specifically porous 3D collagen/chitosan (Col/Chit) scaffolds enhanced with the pro-angiogenic agent dimethyloxalylglycine (DMOG) for dermal wound healing. Scaffolds were fabricated via freeze-drying and crosslinked with carbodiimide agents to improve their mechanical properties. DMOG was incorporated at varying concentrations to stimulate vascular endothelial growth factor production and promote angiogenesis. Physicochemical characterization included scanning electron microscopy and UV-VIS spectroscopy, confirming two-phase release kinetics. In vitro cytotoxicity tests demonstrated good biocompatibility, while in ovo neovascularization studies confirmed enhanced blood vessel formation. In vivo evaluation using a porcine full-thickness wound model showed that DMOG-loaded scaffolds accelerated early healing with more organized wound beds and reduced necrotic tissue compared with the Col/Chit scaffold alone. Histological assessment at three months demonstrated complete skin regeneration with well-developed epidermal and dermal layers, indicating successful long-term tissue remodeling. Furthermore, RT-qPCR analysis at 14 days showed significant upregulation of genes associated with inflammation, tissue remodeling, and angiogenesis, whereas gene expression returned to near-baseline levels after three months, coinciding with complete wound closure. Overall, these findings highlight the potential of DMOG-enhanced protein scaffolds as advanced wound care products for improved clinical healing outcomes.